Clinical, paraclinical characteristics of coronary artery lesions and the results of early treatment of acute coronary syndrome in cancer patients
Main Article Content
Abstract
We conducted a cross-sectional study on 40 patients with acute coronary syndrome (ACS) and cancer at the National Heart Institute in Bach Mai Hospital from August 2023 to September 2024. The study group average age was 72.3 ± 9.0 years old. The three most common types of cancer were colon cancer (20.0%), lung cancer (17.5%), and breast cancer (17.5%). Chest pain was the most common symptom accounting for 95.0%. The number of lesion coronary vessels were: 1 vessel (50.0%), 2 vessels (27.5%), 3 vessels (22.5%), respectively. The two most common types of coronary artery lesions were type C (47.5%), type B1 (32.5%). The average Syntax score was 17.36 ± 12.35. There was 01 patient undergoing coronary artery bypass grafting (CABG), 04 patients were treated medically. There were 35 patients undergoing percutaneous coronary intervention (PCI), of which 01 patient had bleeding complication after the intervention. The in-hospital mortality rate of the entire study group was 0%. There was no statistically significant difference in the characteristics of coronary artery lesions among common cancer groups (gastrointestinal cancer, lung cancer, breast cancer).
Article Details
Keywords
Acute coronary syndrome, cancer
References
2. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3): 229-263. doi:10.3322/caac.21834.
3. Milazzo V, Cosentino N, Campodonico J, et al. Characteristics, Management, and Outcomes of Acute Coronary Syndrome Patients with Cancer. J Clin Med. 2020; 9(11): 3642. doi:10.3390/jcm9113642.
4. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016; 37(36): 2768-2801. doi:10.1093/eurheartj/ehw211.
5. Aronson D, Brenner B. Arterial thrombosis and cancer. Thromb Res. 2018; 164: S23-S28. doi:10.1016/j.thromres.2018.01.003.
6. Das D, Asher A, Ghosh AK. Cancer and Coronary Artery Disease: Common Associations, Diagnosis and Management Challenges. Curr Treat Options Oncol. 2019; 20(6): 46. doi:10.1007/s11864-019-0644-3.
7. Banasiak W, Zymliński R, Undas A. Optimal management of cancer patients with acute coronary syndrome. Pol Arch Intern Med. 2018; 128(4): 244-253. doi:10.20452/pamw.4254.
8. Alyeşil C, Yilmaz S, Özturan İU, Pekdemir M, Yaka E, Doğan NÖ. Reliability of chest pain risk scores in cancer patients with suspected acute coronary syndrome. Clin Exp Emerg Med. 2020; 7(4): 275-280. doi:10.15441/ceem.19.088.
9. Styczkiewicz K, Styczkiewicz M, Myćka M, et al. Clinical presentation and treatment of acute coronary syndrome as well as 1-year survival of patients hospitalized due to cancer: A 7-year experience of a nonacademic center. Medicine (Baltimore). 2020; 99(5): e18972. doi:10.1097/MD.0000000000018972.
10. Ciołek A, Piotrowski G. Interplay between acute coronary syndromes and cancer: insights into pathophysiology, diagnostic challenges, and treatment options. Arch Med Sci Atheroscler Dis. 2023; 8:e190-e195. doi:10.5114/amsad/176660.
11. Bộ Y Tế (2020). Quyết định số 5532/QĐ-BYT về việc ban hành tài liệu chuyên môn “Thực hành chẩn đoán và điều trị bệnh động mạch vành.” Published online 2020.
12. Lannaccone M, D’Ascenzo F, Vadalà P, et al. Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy. Eur Heart J Acute Cardiovasc Care. 2018; 7(7): 631-638. doi:10.1177/2048872617706501.
13. Yousif N, Niederseer D, Davies A, et al. Impact of malignancy on clinical outcomes in patients with acute coronary syndromes. Int J Cardiol. 2021; 328: 8-13. doi:10.1016/j.ijcard.2020.12.010.
14. Tanimura K, Otake H, Kawamori H, et al. Morphological Plaque Characteristics and Clinical Outcomes in Patients With Acute Coronary Syndrome and a Cancer History. J Am Heart Assoc. 2021; 10(15): e020243. doi:10.1161/JAHA.120.020243.
15. Cordero. Prevalence and Postdischarge Incidence of Malignancies in Patients With Acute Coronary Syndrome - PubMed. Accessed September 25, 2024. https://pubmed.ncbi.nlm.nih.gov/29126971/.
16. Branco Mano T, Timóteo AT, Aguiar Rosa S, Belo A, Cruz Ferreira R, ProACS registry Investigators. Cancer patients with acute coronary syndrome have non-superior bleeding risk compared to patients with similar characteristics - a propensity score analysis from the ProACS registry. Rev Port Cardiol Orgao Of Soc Port Cardiol Port J Cardiol Off J Port Soc Cardiol. 2022; 41(7): 573-582. doi:10.1016/j.repc.2021.04.010.